Clinical Report: Mass Spec Behind the Mask

Overview

A modified KN95 mask enables portable detection of exhaled nitric oxide (NO) using mass spectrometry, facilitating on-site analysis for airway inflammation. The method demonstrated reproducible measurements and effective differentiation of NO levels under varying conditions.

Background

Exhaled nitric oxide is a well-established biomarker for assessing airway inflammation, particularly in conditions like asthma. Traditional detection methods are often impractical for near-patient testing.

Data Highlights

The assay delivered reproducible measurements with a detection limit suitable for typical exhaled NO screening ranges within minutes. Humidity had minimal impact on detection performance, while ambient temperature influenced NO capture.

Key Findings

• A modified KN95 mask was developed for exhaled NO detection using mass spectrometry.
• The assay utilized paper strips with amlodipine to react with exhaled NO, forming dehydro amlodipine.
• Direct detection of NO was achieved through paper spray ionization miniature mass spectrometry.
• The method effectively distinguished NO levels after rinsing with ascorbic acid, indicating its sensitivity to changes in exhaled NO.
• Ambient temperature was identified as a critical variable affecting detection performance.

Clinical Implications

This innovative mask-based workflow could provide a practical solution for on-site screening of airway inflammation. Clinicians may consider its application for monitoring patients with inflammatory airway diseases.

Conclusion

The integration of mass spectrometry into a wearable format for NO detection represents a significant advancement in the assessment of airway inflammation. Future studies may further refine its application in clinical practice.

Related Resources & Content

1. NICE, Recommendations | Asthma: diagnosis, monitoring and chronic asthma management, 2024
2. GINA, Global Initiative for Asthma 2025 Strategy Report, 2025
3. NHLBI, Update on Selected Topics in Asthma Management, 2020
4. NCBI, Evidence reviews for FeNO measures to monitor asthma, 2024
5. the analytical scientist — Mass Spec Roundup: From Masterpieces to Microplastics
6. the analytical scientist — Mass Spec Roundup: Molecules, Messages and Fingermarks
7. the analytical scientist — Mass Spec Roundup: Peptides, Particles, Clocks, and Canines
8. the analytical scientist — Mass Spec Roundup: Proteins, Lipids, Pitcher Plants, and Coffee
9. Mass Spec Roundup: From Masterpieces to Microplastics
10. Mass Spec Roundup: Molecules, Messages and Fingermarks
11. Mass Spec Roundup: Peptides, Particles, Clocks, and Canines
12. Recommendations | Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) | Guidance | NICE
13. COPYRIGHTED MATERIAL - DO NOT COPY OR DISTRIBUTE
14. Update on Selected Topics in Asthma Management: A Report from the NAEPPCC Expert Panel Working Group
15. Evidence reviews for FeNO measures to monitor asthma - NCBI Bookshelf
16. Additive prognostic value of blood eosinophils and exhaled nitric oxide (FeNO) to predict asthma attacks in the ORACLE patient-level meta-analysis | European Respiratory Society
17. Utility of exhaled nitric oxide to guide mild asthma treatment in atopic patients and its correlation with asthma control test score: a randomized controlled trial | BMC Pulmonary Medicine | Springer Nature Link
18. ERS technical standard: Global Lung Function Initiative reference values for exhaled nitric oxide fraction (FENO50)
19. Fractional exhaled nitric oxide in acute exacerbations of chronic obstructive pulmonary disease: A meta-analysis with meta-regressions - PubMed